Loading…
Loading…
The moves that matter — curated from across forex, stocks and crypto, and readable in full right here.
Updated 5 Oct, 01:30 am
NETSOL Technologies is set to report Q1 2027 earnings on October 5, 2026, with analysts estimating $0.08 EPS and $15.10 million in revenue. The company delivered a robust fiscal 2026 fourth quarter, achieving record revenue of $20.70 million and a significant increase in net inco
On October 1, 2026, Nexalin Technology (NASDAQ: NXL) , Armada Acquisition Corp. II (NASDAQ: XRPN) , Roze AI (NASDAQ: RZAI) , Mattel (NASDAQ: MAT) , and Accenture (NYSE: ACN) led stock market gainers on heavy volume. Nexalin Technology (NASDAQ: NXL) rose 76.4% to $7.55 on a
Corteva (NYSE: CTVA) , OpenWorld (NASDAQ: OPNW) , Nektar Therapeutics (NASDAQ: NKTR) , Agomab Therapeutics (NASDAQ: AGMB) , and Agenus (NASDAQ: AGEN) posted steep one-day losses on October 1, 2026. Most of the drops are not clearly tied to the day’s headlines. Cortev
Jefferies analyst Roger Song has set a significant $150 price target for Nektar Therapeutics (NASDAQ: NKTR) , indicating substantial potential upside for the biotech stock. Despite promising Phase IIb data for its alopecia treatment drug REZPEG, Nektar's stock experienced a notab
A new union contract for Boeing (NYSE: BA) removes near-term risk to its 737 production, boosting investor confidence. The agreement with its largest white-collar union avoids a potential strike, ensuring stability for critical aircraft programs and deliveries. Shares of the aero
Neogen (NASDAQ: NEOG) is expected to report fiscal first-quarter earnings on October 6, 2026, although reports differ on the exact release timing. Analysts expect adjusted EPS of about $0.05 , while revenue is projected to be roughly flat to slightly lower year over year. An FDA
Stifel cut its price target for Foghorn Therapeutics after a major partnership update with Eli Lilly. Foghorn and Eli Lilly will not advance FHD-909 or a separate selective SMARCA2 degrader program. Foghorn plans to reduce its workforce by about 40% and focus on wholly owned prog
RPM International (NYSE: RPM) is set to release its Q3 2026 earnings report on October 6, 2026, with investors keenly watching its financial performance. Analysts anticipate earnings per share (EPS) of $1.95 and revenue of approximately $2.22 billion , reflecting growth from the
Jefferies raised its price target for Regeneron (NASDAQ: REGN) to $930.00 , indicating significant upside from its current trading price. Regeneron and Sanofi (NASDAQ: SNY) are expanding their collaboration to develop four new long-acting antibodies targeting IL-4 and IL-13 pathw
Close Brothers Group reported adjusted pre-tax profit of £120 million , surpassing expectations of £111 million, primarily due to effective cost management. Despite the profit beat, the specialist lender experienced a 17% drop in adjusted operating profit , highlighti
McCormick & Company (NYSE: MKC) , a leading consumer staples company, reported fiscal third-quarter revenue and adjusted earnings that beat analyst estimates. Net sales increased 17.4%, supported by the McCormick de Mexico acquisition, pricing actions, favorable currency effe
Aehr Test Systems (NASDAQ: AEHR) is anticipated to report strong earnings of $0.11 per share and revenue of approximately $27 million for the quarter ended August 2026, reflecting significant year-over-year growth. The company's fiscal 2027 outlook projects substantial revenue gr
Target (NYSE: TGT) 's recent financial performance, highlighting revenue and gross profit . An analyst upgrade from HSBC, setting a new price target for the retail giant. Key operational efficiency metrics, including operating profit margin and asset turnover . Target (NYSE: TGT)
Piper Sandler set a $16.00 price target for V.F. Corp., representing a 12.20% upside from its previous share price. Analysts forecast a decline in both earnings per share ( $0.51 , down 1.92% ) and revenue ( $2.70 billion , down 3.81% ) for V.F. Corp. Despite a recent daily drop,
Raymond James has increased its price target for e.l.f. Beauty (NYSE:ELF) from $100.00 to $117.00 . e.l.f. Beauty's rhode brand is significantly expanding its retail presence, launching in over 500 Sephora stores across 19 new European markets. The cosmetics company 's stock is c
Beneficient (NASDAQ: BENF) is set to release its Q3 2026 earnings on October 5, 2026, with analysts forecasting $0.97 EPS and $13.1 million revenue. The alternative assets company is pursuing the elimination of debt and equity interests, which it claims are fraudulent, from HCLP
StoneX Financial reiterated a Buy rating and $170 price target for Robinhood Markets (NASDAQ: HOOD) , suggesting significant upside from recent trading levels. Robinhood is expanding its platform with Robinhood Agents, Agent Apps, crypto perpetual futures, earnings contracts, and
Strategic Export License : American Battery Technology Company received U.S. Department of Commerce approval to sell and export up to $100.00 million of recycled battery black mass under specified terms. Facility Expansion & Funding : The company is scaling its current batter
Headlines provided by Investing.com